BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12717004)

  • 61. A type 2A phosphatase-sensitive phosphorylation site controls modal gating of L-type Ca2+ channels in human vascular smooth-muscle cells.
    Groschner K; Schuhmann K; Mieskes G; Baumgartner W; Romanin C
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):513-7. PubMed ID: 8809040
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of Cross-Breeding of Low Phytic Acid MIPS1 and IPK1 Soybean ( Glycine max L. Merr.) Mutants on Their Contents of Inositol Phosphate Isomers.
    Goßner S; Yuan F; Zhou C; Tan Y; Shu Q; Engel KH
    J Agric Food Chem; 2019 Jan; 67(1):247-257. PubMed ID: 30541281
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inositol hexakisphosphate mobilizes an endomembrane store of calcium in guard cells.
    Lemtiri-Chlieh F; MacRobbie EA; Webb AA; Manison NF; Brownlee C; Skepper JN; Chen J; Prestwich GD; Brearley CA
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):10091-5. PubMed ID: 12913129
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diacylglycerol and protein kinase C activate cation channels involved in myogenic tone.
    Slish DF; Welsh DG; Brayden JE
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2196-201. PubMed ID: 12388226
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inositol polyphosphates regulate and predict yeast pseudohyphal growth phenotypes.
    Norman KL; Shively CA; De La Rocha AJ; Mutlu N; Basu S; Cullen PJ; Kumar A
    PLoS Genet; 2018 Jun; 14(6):e1007493. PubMed ID: 29939992
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inositol phosphates and cell signaling: new views of InsP5 and InsP6.
    Menniti FS; Oliver KG; Putney JW; Shears SB
    Trends Biochem Sci; 1993 Feb; 18(2):53-6. PubMed ID: 8387704
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulation of M-like K+ current, IKx, by Ca(2+)-dependent phosphorylation in rod photoreceptors.
    Kurennyi DE; Barnes S
    Am J Physiol; 1997 Jun; 272(6 Pt 1):C1844-53. PubMed ID: 9227413
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phytate (Myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats.
    Grases F; Sanchis P; Perello J; Isern B; Prieto RM; Fernandez-Palomeque C; Fiol M; Bonnin O; Torres JJ
    Front Biosci; 2006 Jan; 11():136-42. PubMed ID: 16146720
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multiple isomers of inositol pentakisphosphate in Epstein-Barr-virus- transformed (T5-1) B-lymphocytes. Identification of inositol 1,3,4,5,6-pentakisphosphate, D-inositol 1,2,4,5,6-pentakisphosphate and L-inositol 1,2,4,5,6-pentakisphosphate.
    McConnell FM; Stephens LR; Shears SB
    Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):323-9. PubMed ID: 1660712
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of alpha-trinositol administered extra- and intracellularly (using liposomes) on rat aorta rings.
    Brailoiu E; Baltatu O; Costuleanu M; Slatineanu S; Filipeanu CM; Branisteanu DD
    Eur J Pharmacol; 1995 Aug; 281(2):209-12. PubMed ID: 7589209
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Physiological levels of PTEN control the size of the cellular Ins(1,3,4,5,6)P(5) pool.
    Deleu S; Choi K; Pesesse X; Cho J; Sulis ML; Parsons R; Shears SB
    Cell Signal; 2006 Apr; 18(4):488-98. PubMed ID: 15979280
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inositol phosphates have novel anticancer function.
    Shamsuddin AM
    J Nutr; 1995 Mar; 125(3 Suppl):725S-732S. PubMed ID: 7884558
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Affinity enrichment and identification of inositol poly- and pyrophosphate interactomes.
    Furkert D; Nadler-Holly M; Fiedler D
    STAR Protoc; 2021 Mar; 2(1):100277. PubMed ID: 33490990
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mass changes of inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate during cell cycle progression in rat thymocytes.
    Guse AH; Greiner E; Emmrich F; Brand K
    J Biol Chem; 1993 Apr; 268(10):7129-33. PubMed ID: 8463248
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Siderophore activity of myo-inositol hexakisphosphate in Pseudomonas aeruginosa.
    Smith AW; Poyner DR; Hughes HK; Lambert PA
    J Bacteriol; 1994 Jun; 176(12):3455-9. PubMed ID: 8206821
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functions, Mechanisms, and therapeutic applications of the inositol pyrophosphates 5PP-InsP
    Qi J; Shi L; Zhu L; Chen Y; Zhu H; Cheng W; Chen AF; Fu C
    J Cardiovasc Transl Res; 2024 Feb; 17(1):197-215. PubMed ID: 37615888
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inositol hexakisphosphate in urine: the relationship between oral intake and urinary excretion.
    Grases F; Simonet BM; March JG; Prieto RM
    BJU Int; 2000 Jan; 85(1):138-42. PubMed ID: 10619962
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid).
    Sakamoto K; Venkatraman G; Shamsuddin AM
    Carcinogenesis; 1993 Sep; 14(9):1815-9. PubMed ID: 7691427
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate.
    Sasakawa N; Sharif M; Hanley MR
    Biochem Pharmacol; 1995 Jul; 50(2):137-46. PubMed ID: 7543266
    [No Abstract]   [Full Text] [Related]  

  • 80. Effects of inositol hexaphosphate on growth and differentiation in K-562 erythroleukemia cell line.
    Shamsuddin AM; Baten A; Lalwani ND
    Cancer Lett; 1992 Jul; 64(3):195-202. PubMed ID: 1638512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.